Skip to main content

POINT Biopharma Global Inc.

PNTDelisted Dec 27, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001811764

POINT Biopharma Global Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Dec 27, 2023; 126 institutions reported holding it in 13F filings for Q3 2023, worth $411.0M in total; no superinvestor held it.

Q3 2023 vs. Q2 2023

How the institutions holding POINT Biopharma Global Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of PNT: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders130126−4
Shares63.0M61.6M−1.41M (−2.2%)
Value$570.6M$411.0M−$159.6M (−28.0%)

New holders (14)

Institutions that held POINT Biopharma Global Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to PNT in Q3 2023
InstitutionSharesValue% of portfolio
Millennium Management LLC851,735$5.68M0.01%
Woodline Partners LP73,796$492.2K0.01%
CIBC World Markets Inc.70,645$471.0K0.00%
HighVista Strategies LLC69,744$465.2K0.22%
Man Group plc–$267.3K0.00%
Franklin Resources Inc37,832$252.3K0.00%
Hudson Bay Capital Management LP36,066$240.6K0.00%
GW Henssler & Associates Ltd24,056$160.5K0.01%
Winton Group Ltd16,056$107.1K0.01%
Squarepoint Ops LLC16,016$106.8K0.00%
DekaBank Deutsche Girozentrale9,092$61.0K0.00%
Russell Investments Group, Ltd.8,128$54.2K0.00%
State of Wyoming4,206$28.1K0.01%
Covestor Ltd13$00.00%

Sold out (18)

Institutions that held POINT Biopharma Global Inc. at the end of Q2 2023 and filed for Q3 2023 without it.